D. Tzemach

发表

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.

H. Shmeeda, Y. Amitay, J. Gorin, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.

H. Shmeeda, Y. Amitay, J. Gorin, 2013, Journal of controlled release : official journal of the Controlled Release Society.

LOCAL HIGH-ORDER ABSORBING BOUNDARY CONDITIONS FOR TIME-DEPENDENT WAVES IN GUIDES

Dan Givoli, Thomas Hagstrom, T. Hagstrom, 2007 .

Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.

H. Shmeeda, D. Tzemach, L. Mak, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models.

D. Tzemach, A. Gabizon, D. Goren, 1999, Anti-cancer drugs.

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

H. Shmeeda, D. Tzemach, A. Gabizon, 2008, Cancer Chemotherapy and Pharmacology.

Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals

D. Tzemach, A. Gabizon, T. Siegal, 1997 .

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models

H. Shmeeda, Y. Amitay, J. Gorin, 2010, Cancer Chemotherapy and Pharmacology.

Reduced Toxicity and Superior Therapeutic Activity of a Mitomycin C Lipid-Based Prodrug Incorporated in Pegylated Liposomes

H. Shmeeda, D. Tzemach, A. Gabizon, 2006, Clinical Cancer Research.

Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.

D. Tzemach, A. Gabizon, D. Goren, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.

H. Shmeeda, Y. Amitay, J. Gorin, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of the relationship between patient factors and the reduction in clearance of pegylated liposomal doxorubicin.

D. Tzemach, A. Gabizon, W. Zamboni, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preclinical Studies with Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes

D. Tzemach, A. Gabizon, O. Pappo, 1993 .

Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids

Yechezkel Barenholz, Alex Sigal, A. Sigal, 2011, PloS one.

Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

D. Tzemach, A. Gabizon, S. Zalipsky, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.

Samuel Zalipsky, H. Shmeeda, D. Tzemach, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.

D. Tzemach, A. Gabizon, S. Zalipsky, 1999, Bioconjugate chemistry.

Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines.

D. Tzemach, A. Gabizon, D. Goren, 1996, Journal of drug targeting.

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

D. Tzemach, A. Gabizon, A. Peyser, 1999, Cancer.

Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models

D. Tzemach, A. Gabizon, Alberto Gabizon, 2002, Journal of drug targeting.

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

H. Shmeeda, D. Tzemach, A. Gabizon, 2006, Molecular Cancer Therapeutics.

Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues

H. Shmeeda, Y. Amitay, D. Tzemach, 2016, Pharmaceutical Research.

Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy

H. Shmeeda, Y. Amitay, D. Tzemach, 2020, Cancer drug resistance.

Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues

H. Shmeeda, Y. Amitay, D. Tzemach, 2015, Pharmaceutical Research.

Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer

Y. Barenholz, H. Shmeeda, Y. Amitay, 2016, Journal of drug targeting.

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

D. Tzemach, A. Gabizon, M. Lotem, 2000, Cancer.

Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity

D. Tzemach, A. Gabizon, S. Zalipsky, 2002 .

Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.

H. Shmeeda, Y. Amitay, D. Tzemach, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.

H. Shmeeda, Y. Amitay, D. Tzemach, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.

D. Tzemach, A. Gabizon, D. Goren, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.